Issues related to implementation of the OTC Drug Monograph User Fee Program reauthorization and non-prescription drug status; Issues related to consumer health care products supply chain; Issues related to FY27 appropriations report language, including H.R. 8646 - Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 and H.R. 8495 - Financial Services and General Government Appropriations Act, 2027.
2026 · 2nd Quarter (Apr 1 - June 30)
CHATTEM, INC. DBA OPELLA
Filed by AKIN GUMP STRAUSS HAUER & FELD.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 20, 2026
- Income
- $70,000.00
- Expenses
- Not reported
- Registrant
- AKIN GUMP STRAUSS HAUER & FELD
- Client
- CHATTEM, INC. DBA OPELLA
- Filing UUID
- b1994376-fb3a-4b54-a59c-15680c8ad8f6
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.